[1]
R. Chaitosa, W. Kumyoo, and K. Paiwattananupant, “Infusion Hypersensitivity Reactions Occurring Beyond the Third Cycle of Paclitaxel in Gynecologic Cancer Patients”, Rama Med J, vol. 41, no. 4, pp. 11–17, Dec. 2018.